Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, et al.
Atherosclerosis (2019) Vol. 284, pp. 66-74
Closed Access | Times Cited: 74

Showing 51-75 of 74 citing articles:

Insufficient nocturnal sleep was associated with a higher risk of fibrosis in patients with diabetes with metabolic associated fatty liver disease
Jiaping Zheng, Sijie Chen, Yuqing Cai, et al.
Therapeutic Advances in Endocrinology and Metabolism (2020) Vol. 11
Open Access | Times Cited: 9
The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Reem Abou Assi, Ibrahim M. Abdulbaqi, Siok Yee Chan
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 215-215
Open Access | Times Cited: 9
Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease
Tingfeng Wu, Junzhao Ye, Xiaorong Gong, et al.
Digestive and Liver Disease (2021) Vol. 53, Iss. 12, pp. 1610-1619
Closed Access | Times Cited: 9
Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial
Won Myung Lee, Jea Hurn Bae, Young Woon Chang, et al.
Nutrients (2021) Vol. 13, Iss. 12, pp. 4453-4453
Open Access | Times Cited: 9
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults
Shuxia Shen, Hangkai Huang, Jinghua Wang, et al.
Digestive Diseases and Sciences (2022) Vol. 68, Iss. 2, pp. 656-664
Closed Access | Times Cited: 5
Atorvastatin impairs liver mitochondrial function in obese Göttingen Minipigs but heart and skeletal muscle are not affected
Liselotte B. Christiansen, Tine Lovsø Dohlmann, Trine Pagh Ludvigsen, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Update on cardiovascular risk in nonalcoholic fatty liver disease
Michael Johnston, Janisha Patel, Christopher D. Byrne
Current Opinion in Cardiology (2021) Vol. 36, Iss. 4, pp. 478-486
Open Access | Times Cited: 6
Statins for treatment of chronic liver disease
Mohamad Kareem Marrache, Don C. Rockey
Current Opinion in Gastroenterology (2021) Vol. 37, Iss. 3, pp. 200-207
Open Access | Times Cited: 6
Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis
Walter Masson, Martín Lobo, Gerardo Masson, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 5, pp. 1357-1364
Closed Access | Times Cited: 5
A Novel Mutation in LXRα Uncovers a Role for Cholesterol Sensing in Limiting Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Alexis T. Clark, Lillian Russo-Savage, Luke A. Ashton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Comprehensive Framework for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: Analyzing Novel Risk Factors and Advances in Nanotechnology-Based Treatments and Diagnosis
Lucia M. Chávez-López, Gabriela I. Carballo-López, Karina del Carmen Lugo-Ibarra, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2622-2642
Closed Access
Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)
Davide Misceo, Gabriele Mocciaro, Simona D’Amore, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access
Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology
Stergios A. Pοlyzos, Jannis Kountouras
Journal of Clinical Gastroenterology (2019) Vol. 53, Iss. 8, pp. 624-626
Closed Access | Times Cited: 3
Prebiotic‐Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver Health
Jin‐Jin Cui, Rui Li, Xiaolei Ma, et al.
Small Structures (2023) Vol. 4, Iss. 8
Open Access | Times Cited: 1
The Role of C-reactive Protein in Aging associated NAFLD
Zheng Ding, Yuqiu Wei, Jing Peng, et al.
(2023)
Open Access | Times Cited: 1
Phenotypic Response and Personalized Medicine in Liver Cancer and Transplantation: Approaches to Complex Systems
Ali Zarrinpar, Un Bi Kim, Vijay P. Boominathan
Advanced Therapeutics (2020) Vol. 3, Iss. 4
Closed Access | Times Cited: 2
Editorial: statin use in patients with NAFLD—safety concerns, decreased awareness or both?
Maxime Mallet, Raluca Pais
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 11-12, pp. 1499-1500
Open Access | Times Cited: 2
Diabetes and hepatocellular carcinoma risks in patients with nonalcoholic steatohepatitis related cirrhosis
Chien‐Hsieh Chiang, Kuo‐Chin Huang
HepatoBiliary Surgery and Nutrition (2020) Vol. 9, Iss. 3, pp. 357-359
Open Access | Times Cited: 1
A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
Robert Schierwagen, Sabine Klein, Jonel Trebicka
Cellular and Molecular Gastroenterology and Hepatology (2020) Vol. 10, Iss. 3, pp. 649-651
Open Access | Times Cited: 1
Statins in liver cirrhosis in a developing country: benefits overweigh the risk?
Jhean Gabriel Gonzáles Yovera, Marcio José Concepción‐Zavaleta, Diego Martín Moreno Marreros, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 12, pp. 1651-1652
Open Access | Times Cited: 1
Mechanism for FXR to regulate bile acid and glycolipid metabolism to improve NAFLD
Zhi Huang, Rongrong Zhou
Shijie huaren xiaohua zazhi (2023) Vol. 31, Iss. 19, pp. 797-807
Open Access
Use of statins in adults over 80 years old
Angeli Edith Penzzi González
Revista Virtual de la Sociedad Paraguaya de Medicina Interna (2020) Vol. 7, Iss. 1, pp. 96-106
Open Access
Corrigendum to: Nudging within learning health systems: next generation decision support to improve cardiovascular care

European Heart Journal (2022) Vol. 43, Iss. 21, pp. 2033-2033
Open Access
Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
A. E. Bagriy, A. D. Zubov, M V Khomenko, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2021) Vol. 31, Iss. 2, pp. 14-26
Open Access
Previous Page - Page 3

Scroll to top